Newsroom: Confluent Announces Significant Investment in ATI Nitinol Melt Expansion

A Message From Our CEO Regarding COVID-19

Confluent Medical has been actively monitoring the rapidly moving changes of the novel coronavirus (COVID-19). Our priority remains the health and safety of our employees and our customers, while delivering the same quality products to which you have become accustomed. Like you, we continue to monitor news from the World Health Organization (WHO) , the U.S. Centers for Disease Control (CDC) and local governments and we are committed to ensuring the safety of our broad Confluent family. To that end, we wanted you to be aware of what we are doing to ensure safety at all levels.

Please be assured that Confluent Medical staff at all our locations are in contact with our suppliers and vendors and currently do not foresee any disruptions. Of course, we will continue to monitor the evolving situation and notify customers proactively.

In terms of employee safety, we are adhering to all CDC guidelines, including routine washing of hands and social distancing. We continue to reinforce these guidelines and the ongoing need to stay home if anyone should feel sick. Travel will be severely limited and meetings will be held virtually where possible. We are also enacting a selective but required remote work schedule for our facilities in high impact geographies or that have greater than 100 employees within a single building.

We remain committed to being vigilant in monitoring the evolving situation and to keeping our employees and valued customers abreast of all changes. We understand we all need to be flexible in times like this and our pledge to you is to remain open and honest at all times.

Sincerely,

Dean Schauer
Chief Executive Officer / President

Newsroom

Latest News

September 10, 2024

Dean Schauer Appointed Chairman of the Board of Confluent Medical Technologies 

Read More ›
March 8, 2024

Confluent Appoints Sandy Stojkovski and Brian Yoor to its Board of Directors

Read More ›
January 25, 2024

Confluent Announces Significant Investment in ATI Nitinol Melt Expansion

Read More ›

Partnering with you every step of the way

Contact Confluent Medical today and make sure your project is supported by our unmatched resources, technical expertise and proven service to meet any design, modification or manufacturing requirements.